{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:10Z","timestamp":1792788310573,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SPP 2084: \u00b5BONE"],"award-info":[{"award-number":["SPP 2084: \u00b5BONE"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["#401326337"],"award-info":[{"award-number":["#401326337"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG SPP 2084: \u00b5BONE"],"award-info":[{"award-number":["DFG SPP 2084: \u00b5BONE"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["#491716269"],"award-info":[{"award-number":["#491716269"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helmholtz-Zentrum Dresden - Rossendorf e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is the second most common type of tumor diagnosed in men and the fifth leading cause of cancer-related death in male patients. The response of metastatic disease to standard treatment is heterogeneous. As for now, there is no curative treatment option available for metastatic PCa, and the clinical tests capable of predicting metastatic dissemination and metastatic response to the therapies are lacking. Our recent study identified aldehyde dehydrogenases ALDH1A1 and ALDH1A3 as critical regulators of PCa metastases. Still, the exact mechanisms mediating the role of these proteins in PCa metastatic dissemination remain not fully understood, and plasma-based biomarkers of these metastatic mechanisms are not available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genetic silencing, gene overexpression, or treatment with different concentrations of the retinoic acid (RA) isomers, which are the products of ALDH catalytic activity, were used to modulate the interplay between retinoic acid receptors (RARs) and androgen receptor (AR). RNA sequencing (RNAseq), reporter gene assays, and chromatin immunoprecipitation (ChIP) analysis were employed to validate the role of RARs and AR in the regulation of the transforming growth factor-beta 1 (TGFB1) expression. Gene expression levels of ALDH1A1, ALDH1A3, and the matrix metalloproteinase 11 (MMP11) and their correlation with pathological parameters and clinical outcomes were analysed by mining several publicly available patient datasets as well as our multi-center transcriptomic dataset from patients with high-risk and locally advanced PCa. The level of MMP11 protein was analysed by enzyme-linked immunosorbent assay (ELISA) in independent cohorts of plasma samples from patients with primary or metastatic PCa and healthy donors, while plasma proteome profiles were obtained for selected subsets of PCa patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We could show that ALDH1A1 and ALDH1A3 genes differently regulate TGFB1 expression in a RAR- and AR-dependent manner. We further observed that the TGF-\u03b21 pathway contributes to the regulation of the MMPs, including MMP11. We have confirmed the relevance of MMP11 as a promising clinical marker for PCa using several independent gene expression datasets. Further, we have validated plasma MMP11 level as a prognostic biomarker in patients with metastatic PCa. Finally, we proposed a hypothetical ALDH1A1\/MMP11-related plasma proteome-based prognostic signature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TGFB1\/MMP11 signaling contributes to the ALDH1A1-driven PCa metastases. MMP11 is a promising blood-based biomarker of PCa progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03299-6","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T22:29:17Z","timestamp":1742768957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-\u03b21 signaling mechanism"],"prefix":"10.1186","volume":"44","author":[{"given":"Ielizaveta","family":"Gorodetska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasyl","family":"Lukiyanchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslava","family":"Sliusar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Fuessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Borkowetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wojakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fochtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Leal-Ega\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Sedef","family":"K\u00f6seer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U\u011fur","family":"Kahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"P\u00fcschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Klusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Peitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Kronstein-Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Tonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Marczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wid\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Pietrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dubrovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"issue":"3","key":"3299_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3299_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3299_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2015.06.021","volume":"367","author":"A Katzenwadel","year":"2015","unstructured":"Katzenwadel A, Wolf P. Androgen deprivation of prostate cancer: Leading to a therapeutic dead end. Cancer Lett. 2015;367(1):12\u20137.","journal-title":"Cancer Lett"},{"issue":"5","key":"3299_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578\u201383.","journal-title":"Hum Pathol"},{"key":"3299_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2018.01.018","volume":"418","author":"X Meng","year":"2018","unstructured":"Meng X, Vander Ark A, Daft P, Woodford E, Wang J, Madaj Z, et al. Loss of TGF-beta signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis. Cancer Lett. 2018;418:109\u201318.","journal-title":"Cancer Lett"},{"issue":"1","key":"3299_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajur.2018.11.005","volume":"6","author":"L Dong","year":"2019","unstructured":"Dong L, Zieren RC, Xue W, de Reijke TM, Pienta KJ. Metastatic prostate cancer remains incurable, why? Asian J Urol. 2019;6(1):26\u201341.","journal-title":"Asian J Urol"},{"issue":"8","key":"3299_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41571-021-00499-9","volume":"18","author":"LC Hofbauer","year":"2021","unstructured":"Hofbauer LC, Bozec A, Rauner M, Jakob F, Perner S, Pantel K. Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol. 2021;18(8):488\u2013505.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3299_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"C Gialeli","year":"2011","unstructured":"Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011;278(1):16\u201327.","journal-title":"FEBS J"},{"issue":"2","key":"3299_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jcp.10092","volume":"191","author":"MJ Wilson","year":"2002","unstructured":"Wilson MJ, Sellers RG, Wiehr C, Melamud O, Pei D, Peehl DM. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol. 2002;191(2):208\u201316.","journal-title":"J Cell Physiol"},{"issue":"2","key":"3299_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1091\/mbc.10.2.407","volume":"10","author":"I Sehgal","year":"1999","unstructured":"Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell. 1999;10(2):407\u201316.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"3299_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/endocrines4020027","volume":"4","author":"C Sorrentino","year":"2023","unstructured":"Sorrentino C, D\u2019Angiolo R, Gentile G, Giovannelli P, Perillo B, Migliaccio A, et al. The Androgen Regulation of Matrix Metalloproteases in Prostate Cancer and Its Related Tumor Microenvironment. Endocrines. 2023;4(2):350\u201365.","journal-title":"Endocrines"},{"key":"3299_CR12","doi-asserted-by":"crossref","unstructured":"Trivedi T, Pagnotti GM, Guise TA, Mohammad KS. The Role of TGF-beta in Bone Metastases. Biomolecules. 2021;11(11):1643.","DOI":"10.3390\/biom11111643"},{"issue":"16","key":"3299_CR13","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1158\/0008-5472.CAN-05-4451","volume":"66","author":"M Ao","year":"2006","unstructured":"Ao M, Williams K, Bhowmick NA, Hayward SW. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 2006;66(16):8007\u201316.","journal-title":"Cancer Res"},{"issue":"2","key":"3299_CR14","first-page":"78","volume":"1","author":"C Lee","year":"2012","unstructured":"Lee C, Zhang Q, Zi X, Dash A, Soares MB, Rahmatpanah F, et al. TGF-beta mediated DNA methylation in prostate cancer. Transl Androl Urol. 2012;1(2):78\u201388.","journal-title":"Transl Androl Urol"},{"issue":"7","key":"3299_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/bjc.2016.255","volume":"115","author":"C Bellomo","year":"2016","unstructured":"Bellomo C, Caja L, Moustakas A. Transforming growth factor beta as regulator of cancer stemness and metastasis. Br J Cancer. 2016;115(7):761\u20139.","journal-title":"Br J Cancer"},{"issue":"11","key":"3299_CR16","doi-asserted-by":"publisher","first-page":"e0242809","DOI":"10.1371\/journal.pone.0242809","volume":"15","author":"B Yuan","year":"2020","unstructured":"Yuan B, El Dana F, Ly S, Yan Y, Ruvolo V, Shpall EJ, et al. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-beta-p38-ALDH2 pathway. PLoS ONE. 2020;15(11):e0242809.","journal-title":"PLoS ONE"},{"issue":"3","key":"3299_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.4020","volume":"228","author":"Y Katsuno","year":"2012","unstructured":"Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-beta. J Pathol. 2012;228(3):391\u2013404.","journal-title":"J Pathol"},{"issue":"5","key":"3299_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.ajpath.2015.01.011","volume":"185","author":"Y Hoshino","year":"2015","unstructured":"Hoshino Y, Nishida J, Katsuno Y, Koinuma D, Aoki T, Kokudo N, et al. Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1. Am J Pathol. 2015;185(5):1457\u201370.","journal-title":"Am J Pathol"},{"issue":"18","key":"3299_CR19","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.3390\/cancers13184703","volume":"13","author":"J Puschel","year":"2021","unstructured":"Puschel J, Dubrovska A, Gorodetska I. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells. Cancers (Basel). 2021;13(18):4703.","journal-title":"Cancers (Basel)"},{"issue":"1\u20133","key":"3299_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","volume":"202","author":"V Vasiliou","year":"2013","unstructured":"Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact. 2013;202(1\u20133):2\u201310.","journal-title":"Chem Biol Interact"},{"issue":"3","key":"3299_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/exd.12099","volume":"22","author":"EK Paterson","year":"2013","unstructured":"Paterson EK, Ho H, Kapadia R, Ganesan AK. 9-cis retinoic acid is the ALDH1A1 product that stimulates melanogenesis. Exp Dermatol. 2013;22(3):202\u20139.","journal-title":"Exp Dermatol"},{"key":"3299_CR22","doi-asserted-by":"publisher","first-page":"108256","DOI":"10.1016\/j.abb.2020.108256","volume":"681","author":"R Pequerul","year":"2020","unstructured":"Pequerul R, Vera J, Gimenez-Dejoz J, Crespo I, Coines J, Porte S, et al. Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis. Arch Biochem Biophys. 2020;681:108256.","journal-title":"Arch Biochem Biophys"},{"issue":"35","key":"3299_CR23","doi-asserted-by":"publisher","first-page":"31491","DOI":"10.1074\/jbc.M205016200","volume":"277","author":"N Idres","year":"2002","unstructured":"Idres N, Marill J, Flexor MA, Chabot GG. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem. 2002;277(35):31491\u20138.","journal-title":"J Biol Chem"},{"issue":"2","key":"3299_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0092-8674(92)90479-V","volume":"68","author":"RA Heyman","year":"1992","unstructured":"Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992;68(2):397\u2013406.","journal-title":"Cell"},{"issue":"10","key":"3299_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/cmdc.201600105","volume":"11","author":"AR de Lera","year":"2016","unstructured":"de Lera AR, Krezel W, Ruhl R. An Endogenous Mammalian Retinoid X Receptor Ligand, At Last! ChemMedChem. 2016;11(10):1027\u201337.","journal-title":"ChemMedChem"},{"issue":"11","key":"3299_CR26","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1093\/emboj\/19.11.2592","volume":"19","author":"PF Egea","year":"2000","unstructured":"Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P, Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 2000;19(11):2592\u2013601.","journal-title":"EMBO J"},{"issue":"sup1","key":"3299_CR27","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","volume":"59","author":"X Ni","year":"2019","unstructured":"Ni X, Hu G, Cai X. The success and the challenge of all-trans retinoic acid in the treatment of cancer. Crit Rev Food Sci Nutr. 2019;59(sup1):S71\u201380.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"3299_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molonc.2014.09.005","volume":"9","author":"A Doi","year":"2015","unstructured":"Doi A, Ishikawa K, Shibata N, Ito E, Fujimoto J, Yamamoto M, et al. Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures. Mol Oncol. 2015;9(2):355\u201364.","journal-title":"Mol Oncol"},{"issue":"29","key":"3299_CR29","doi-asserted-by":"publisher","first-page":"17690","DOI":"10.1074\/jbc.M115.638510","volume":"290","author":"A Zanetti","year":"2015","unstructured":"Zanetti A, Affatato R, Centritto F, Fratelli M, Kurosaki M, Barzago MM, et al. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFbeta). J Biol Chem. 2015;290(29):17690\u2013709.","journal-title":"J Biol Chem"},{"issue":"5","key":"3299_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1183\/09031936.00195708","volume":"34","author":"C Tabata","year":"2009","unstructured":"Tabata C, Tabata R, Hirayama N, Yasumitsu A, Yamada S, Murakami A, et al. All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice. Eur Respir J. 2009;34(5):1159\u201367.","journal-title":"Eur Respir J"},{"key":"3299_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1476-4598-6-82","volume":"6","author":"B Singh","year":"2007","unstructured":"Singh B, Murphy RF, Ding XZ, Roginsky AB, Bell RH Jr, Adrian TE. On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells. Mol Cancer. 2007;6:82.","journal-title":"Mol Cancer"},{"issue":"7","key":"3299_CR32","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1158\/0008-5472.CAN-14-1924","volume":"75","author":"M Cojoc","year":"2015","unstructured":"Cojoc M, Peitzsch C, Kurth I, Trautmann F, Kunz-Schughart LA, Telegeev GD, et al. Aldehyde Dehydrogenase Is Regulated by beta-Catenin\/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. Cancer Res. 2015;75(7):1482\u201394.","journal-title":"Cancer Res"},{"issue":"17","key":"3299_CR33","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-15-2956","volume":"22","author":"X Chen","year":"2016","unstructured":"Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, et al. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer. Clin Cancer Res. 2016;22(17):4505\u201316.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3299_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/labinvest.2009.127","volume":"90","author":"T Li","year":"2010","unstructured":"Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, et al. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients\u2019 outcome. Lab Invest. 2010;90(2):234\u201344.","journal-title":"Lab Invest"},{"issue":"12","key":"3299_CR35","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-09-3806","volume":"70","author":"C van den Hoogen","year":"2010","unstructured":"van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N, et al. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res. 2010;70(12):5163\u201373.","journal-title":"Cancer Res"},{"issue":"19","key":"3299_CR36","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1158\/1078-0432.CCR-12-2857","volume":"19","author":"C Le Magnen","year":"2013","unstructured":"Le Magnen C, Bubendorf L, Rentsch CA, Mengus C, Gsponer J, Zellweger T, et al. Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clin Cancer Res. 2013;19(19):5361\u201371.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3299_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1158\/1541-7786.MCR-21-0806","volume":"20","author":"FM Schwarz","year":"2022","unstructured":"Schwarz FM, Schniewind I, Besso MJ, Lange S, Linge A, Patil SG, et al. Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity. Mol Cancer Res. 2022;20(5):794\u2013809.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"3299_CR38","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/ijc.32323","volume":"145","author":"I Gorodetska","year":"2019","unstructured":"Gorodetska I, Lukiyanchuk V, Peitzsch C, Kozeretska I, Dubrovska A. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype. Int J Cancer. 2019;145(11):2974\u201385.","journal-title":"Int J Cancer"},{"issue":"9","key":"3299_CR39","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1158\/0008-5472.CAN-15-2116","volume":"76","author":"C Peitzsch","year":"2016","unstructured":"Peitzsch C, Cojoc M, Hein L, Kurth I, Mabert K, Trautmann F, et al. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells. Cancer Res. 2016;76(9):2637\u201351.","journal-title":"Cancer Res"},{"issue":"2","key":"3299_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7150\/thno.88057","volume":"14","author":"I Gorodetska","year":"2024","unstructured":"Gorodetska I, Offermann A, Puschel J, Lukiyanchuk V, Gaete D, Kurzyukova A, et al. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 2024;14(2):714\u201337.","journal-title":"Theranostics"},{"issue":"33","key":"3299_CR41","doi-asserted-by":"publisher","first-page":"34494","DOI":"10.18632\/oncotarget.5417","volume":"6","author":"I Kurth","year":"2015","unstructured":"Kurth I, Hein L, Mabert K, Peitzsch C, Koi L, Cojoc M, et al. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. 2015;6(33):34494\u2013509.","journal-title":"Oncotarget"},{"key":"3299_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.actbio.2022.02.010","volume":"142","author":"O Ertekin","year":"2022","unstructured":"Ertekin O, Monavari M, Kruger R, Fuentes-Chandia M, Parma B, Letort G, et al. 3D hydrogel-based microcapsules as an in vitro model to study tumorigenicity, cell migration and drug resistance. Acta Biomater. 2022;142:208\u201320.","journal-title":"Acta Biomater"},{"key":"3299_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ab.2019.04.022","volume":"577","author":"R Zolfaghari","year":"2019","unstructured":"Zolfaghari R, Mattie FJ, Wei CH, Chisholm DR, Whiting A, Ross AC. CYP26A1 gene promoter is a useful tool for reporting RAR-mediated retinoid activity. Anal Biochem. 2019;577:98\u2013109.","journal-title":"Anal Biochem"},{"issue":"4","key":"3299_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41556-018-0062-y","volume":"20","author":"HW Yeh","year":"2018","unstructured":"Yeh HW, Hsu EC, Lee SS, Lang YD, Lin YC, Chang CY, et al. PSPC1 mediates TGF-beta1 autocrine signalling and Smad2\/3 target switching to promote EMT, stemness and metastasis. Nat Cell Biol. 2018;20(4):479\u201391.","journal-title":"Nat Cell Biol"},{"issue":"15","key":"3299_CR45","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/pros.21010","volume":"69","author":"CA Power","year":"2009","unstructured":"Power CA, Pwint H, Chan J, Cho J, Yu Y, Walsh W, et al. A novel model of bone-metastatic prostate cancer in immunocompetent mice. Prostate. 2009;69(15):1613\u201323.","journal-title":"Prostate"},{"issue":"12","key":"3299_CR46","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1021\/pr900748n","volume":"8","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Mann M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res. 2009;8(12):5674\u20138.","journal-title":"J Proteome Res"},{"issue":"5","key":"3299_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359\u201362.","journal-title":"Nat Methods"},{"issue":"D1","key":"3299_CR48","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3299_CR49","first-page":"D1145","volume":"48","author":"EW Deutsch","year":"2020","unstructured":"Deutsch EW, Bandeira N, Sharma V, Perez-Riverol Y, Carver JJ, Kundu DJ, et al. The ProteomeXchange consortium in 2020: enabling \u201cbig data\u201d approaches in proteomics. Nucleic Acids Res. 2020;48(D1):D1145\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"3299_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018;173(2):321-37e10.","journal-title":"Cell."},{"issue":"23","key":"3299_CR51","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci U S A. 2019;116(23):11428\u201336.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3299_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11\u201322.","journal-title":"Cancer Cell"},{"issue":"6","key":"3299_CR53","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser C, Favero F, Risch T, Simon R, Feuerbach L, Assenov Y, et al. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories. Cancer Cell. 2018;34(6):996-1011 e8.","journal-title":"Cancer Cell"},{"key":"3299_CR54","doi-asserted-by":"crossref","unstructured":"Ren S, Wei GH, Liu D, Wang L, Hou Y, Zhu S, Peng L, Zhang Q, Cheng Y, Su H, Zhou X, Zhang J, Li F, Zheng H, Zhao Z, Yin C, He Z, Gao X, Zhau HE, Chu CY, Wu JB, Collins C, Volik SV, Bell R, Huang J, Wu K, Xu D, Ye D, Yu Y, Zhu L, Qiao M, Lee HM, Yang Y, Zhu Y, Shi X, Chen R, Wang Y, Xu W, Cheng Y, Xu C, Gao X, Zhou T, Yang B, Hou J, Liu L, Zhang Z, Zhu Y, Qin C, Shao P, Pang J, Chung LWK, Xu J, Wu CL, Zhong W, Xu X, Li Y, Zhang X, Wang J, Yang H, Wang J, Huang H, Sun Y. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression. Eur Urol. 2018;73(3):322\u201339.","DOI":"10.1016\/j.eururo.2017.08.027"},{"issue":"6","key":"3299_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012;44(6):685\u20139.","journal-title":"Nat Genet"},{"issue":"11","key":"3299_CR56","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete JT, Gyorffy B. ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer. 2019;145(11):3140\u201351.","journal-title":"Int J Cancer"},{"issue":"2","key":"3299_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.32614\/RJ-2016-042","volume":"8","author":"D Goksuluk","year":"2016","unstructured":"Goksuluk D, Korkmaz S, Zararsiz G, Karaagaoglu AE. easyROC: An Interactive Web-tool for ROC Curve Analysis Using R Language Environment. The R Journal. 2016;8(2):213\u201330.","journal-title":"The R Journal"},{"key":"3299_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","volume":"44","author":"C Peitzsch","year":"2017","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: The root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10\u201324.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3299_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1152\/physiolgenomics.00303.2004","volume":"21","author":"G Karlsson","year":"2005","unstructured":"Karlsson G, Liu Y, Larsson J, Goumans MJ, Lee JS, Thorgeirsson SS, et al. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol Genomics. 2005;21(3):396\u2013403.","journal-title":"Physiol Genomics"},{"issue":"4","key":"3299_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/carcin\/bgv018","volume":"36","author":"MJ Young","year":"2015","unstructured":"Young MJ, Wu YH, Chiu WT, Weng TY, Huang YF, Chou CY. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells. Carcinogenesis. 2015;36(4):498\u2013507.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3299_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1124\/jpet.104.072496","volume":"312","author":"JS Moreb","year":"2005","unstructured":"Moreb JS, Gabr A, Vartikar GR, Gowda S, Zucali JR, Mohuczy D. Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde. J Pharmacol Exp Ther. 2005;312(1):339\u201345.","journal-title":"J Pharmacol Exp Ther"},{"issue":"78","key":"3299_CR62","doi-asserted-by":"publisher","first-page":"34658","DOI":"10.18632\/oncotarget.26157","volume":"9","author":"SR Modarai","year":"2018","unstructured":"Modarai SR, Gupta A, Opdenaker LM, Kowash R, Masters G, Viswanathan V, et al. The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells. Oncotarget. 2018;9(78):34658\u201369.","journal-title":"Oncotarget"},{"issue":"2","key":"3299_CR63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1194\/jlr.M054718","volume":"56","author":"SL Arnold","year":"2015","unstructured":"Arnold SL, Kent T, Hogarth CA, Schlatt S, Prasad B, Haenisch M, et al. Importance of ALDH1A enzymes in determining human testicular retinoic acid concentrations. J Lipid Res. 2015;56(2):342\u201357.","journal-title":"J Lipid Res"},{"issue":"D1","key":"3299_CR64","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute I, Riudavets-Puig R, Blanc-Mathieu R, Castro-Mondragon JA, Ferenc K, Kumar V, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2024;52(D1):D174\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3299_CR65","doi-asserted-by":"publisher","first-page":"764727","DOI":"10.3389\/fcell.2021.764727","volume":"9","author":"CH Stuelten","year":"2021","unstructured":"Stuelten CH, Zhang YE. Transforming Growth Factor-beta: An Agent of Change in the Tumor Microenvironment. Front Cell Dev Biol. 2021;9:764727.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"3299_CR66","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.2353\/ajpath.2007.060720","volume":"170","author":"RD Bonfil","year":"2007","unstructured":"Bonfil RD, Dong Z, Trindade Filho JC, Sabbota A, Osenkowski P, Nabha S, et al. Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth. Am J Pathol. 2007;170(6):2100\u201311.","journal-title":"Am J Pathol"},{"issue":"12","key":"3299_CR67","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/carcin\/bgl078","volume":"27","author":"K Jungert","year":"2006","unstructured":"Jungert K, Buck A, Buchholz M, Wagner M, Adler G, Gress TM, et al. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis. 2006;27(12):2392\u2013401.","journal-title":"Carcinogenesis"},{"issue":"21","key":"3299_CR68","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.18632\/oncotarget.2536","volume":"5","author":"F Yang","year":"2014","unstructured":"Yang F, Chen Y, Shen T, Guo D, Dakhova O, Ittmann MM, et al. Stromal TGF-beta signaling induces AR activation in prostate cancer. Oncotarget. 2014;5(21):10854\u201369.","journal-title":"Oncotarget"},{"issue":"1","key":"3299_CR69","first-page":"44","volume":"56","author":"IY Kim","year":"1996","unstructured":"Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, et al. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res. 1996;56(1):44\u20138.","journal-title":"Cancer Res"},{"issue":"9","key":"3299_CR70","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1210\/me.2005-0096","volume":"19","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Rubenstein JN, Jang TL, Pins M, Javonovic B, Yang X, et al. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP). Mol Endocrinol. 2005;19(9):2390\u20139.","journal-title":"Mol Endocrinol"},{"issue":"3","key":"3299_CR71","doi-asserted-by":"publisher","first-page":"e0283159","DOI":"10.1371\/journal.pone.0283159","volume":"18","author":"SB Jacobsen","year":"2023","unstructured":"Jacobsen SB, Tfelt-Hansen J, Smerup MH, Andersen JD, Morling N. Comparison of whole transcriptome sequencing of fresh, frozen, and formalin-fixed, paraffin-embedded cardiac tissue. PLoS ONE. 2023;18(3):e0283159.","journal-title":"PLoS ONE"},{"issue":"W1","key":"3299_CR72","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"3299_CR73","doi-asserted-by":"publisher","first-page":"1323961","DOI":"10.3389\/fonc.2024.1323961","volume":"14","author":"A Wojakowska","year":"2024","unstructured":"Wojakowska A, Marczak L, Zeman M, Chekan M, Zembala-Nozynska E, Polanski K, et al. Proteomic and metabolomic signatures of rectal tumor discriminate patients with different responses to preoperative radiotherapy. Front Oncol. 2024;14:1323961.","journal-title":"Front Oncol"},{"issue":"3","key":"3299_CR74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","volume":"14","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Huang X, Ebert D, Mills C, Guo X, et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc. 2019;14(3):703\u201321.","journal-title":"Nat Protoc"},{"issue":"1","key":"3299_CR75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ccell.2019.12.004","volume":"37","author":"NJ Birkbak","year":"2020","unstructured":"Birkbak NJ, McGranahan N. Cancer Genome Evolutionary Trajectories in Metastasis. Cancer Cell. 2020;37(1):8\u201319.","journal-title":"Cancer Cell"},{"issue":"1","key":"3299_CR76","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41467-018-03877-7","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Cao X, An Q, Zhang Y, Li K, Yao W, et al. Inhibition of cancer stem cell like cells by a synthetic retinoid. Nat Commun. 2018;9(1):1406.","journal-title":"Nat Commun"},{"issue":"2","key":"3299_CR77","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcp.22417","volume":"226","author":"LJ Gudas","year":"2011","unstructured":"Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. J Cell Physiol. 2011;226(2):322\u201330.","journal-title":"J Cell Physiol"},{"issue":"4","key":"3299_CR78","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/1541-7786.MCR-20-0462","volume":"19","author":"M Bauzone","year":"2021","unstructured":"Bauzone M, Souidi M, Dessein AF, Wisztorski M, Vincent A, Gimeno JP, et al. Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells. Mol Cancer Res. 2021;19(4):612\u201322.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3299_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41698-023-00411-x","volume":"7","author":"K Lavudi","year":"2023","unstructured":"Lavudi K, Banerjee A, Li N, Yang Y, Cai S, Bai X, et al. ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase theta expression. NPJ Precis Oncol. 2023;7(1):66.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"3299_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans RM, Mangelsdorf DJ. Nuclear Receptors, RXR, and the Big Bang. Cell. 2014;157(1):255\u201366.","journal-title":"Cell"},{"issue":"21","key":"3299_CR81","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.1128\/MCB.23.21.7678-7688.2003","volume":"23","author":"V Vivat-Hannah","year":"2003","unstructured":"Vivat-Hannah V, Bourguet W, Gottardis M, Gronemeyer H. Separation of retinoid X receptor homo- and heterodimerization functions. Mol Cell Biol. 2003;23(21):7678\u201388.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"3299_CR82","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1093\/nar\/gks143","volume":"40","author":"GC Rivera-Gonzalez","year":"2012","unstructured":"Rivera-Gonzalez GC, Droop AP, Rippon HJ, Tiemann K, Pellacani D, Georgopoulos LJ, et al. Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance. Nucleic Acids Res. 2012;40(11):4825\u201340.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3299_CR83","first-page":"318","volume":"9","author":"B Thompson-Elliott","year":"2021","unstructured":"Thompson-Elliott B, Johnson R, Khan SA. Alterations in TGFbeta signaling during prostate cancer progression. Am J Clin Exp Urol. 2021;9(4):318\u201328.","journal-title":"Am J Clin Exp Urol"},{"issue":"11","key":"3299_CR84","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1200\/JCO.2001.19.11.2856","volume":"19","author":"SF Shariat","year":"2001","unstructured":"Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM, et al. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy. J Clin Oncol. 2001;19(11):2856\u201364.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3299_CR85","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1158\/1078-0432.CCR-0768-03","volume":"10","author":"SF Shariat","year":"2004","unstructured":"Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, et al. Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression. Clin Cancer Res. 2004;10(6):1992\u20139.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3299_CR86","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1158\/0008-5472.CAN-13-2652","volume":"74","author":"A Araujo","year":"2014","unstructured":"Araujo A, Cook LM, Lynch CC, Basanta D. An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer. Cancer Res. 2014;74(9):2391\u2013401.","journal-title":"Cancer Res"},{"issue":"11","key":"3299_CR87","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.7150\/ijms.46780","volume":"17","author":"X Geng","year":"2020","unstructured":"Geng X, Chen C, Huang Y, Hou J. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer. Int J Med Sci. 2020;17(11):1550\u201360.","journal-title":"Int J Med Sci"},{"issue":"6","key":"3299_CR88","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.21037\/tau-20-1019","volume":"9","author":"X Wu","year":"2020","unstructured":"Wu X, Lv D, Eftekhar M, Khan A, Cai C, Zhao Z, et al. A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients. Transl Androl Urol. 2020;9(6):2572\u201386.","journal-title":"Transl Androl Urol"},{"issue":"5","key":"3299_CR89","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/sj.bjc.6605569","volume":"102","author":"S Escaff","year":"2010","unstructured":"Escaff S, Fernandez JM, Gonzalez LO, Suarez A, Gonzalez-Reyes S, Gonzalez JM, et al. Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer. 2010;102(5):922\u20139.","journal-title":"Br J Cancer"},{"issue":"12","key":"3299_CR90","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-08-3226","volume":"15","author":"D Peruzzi","year":"2009","unstructured":"Peruzzi D, Mori F, Conforti A, Lazzaro D, De Rinaldis E, Ciliberto G, et al. MMP11: a novel target antigen for cancer immunotherapy. Clin Cancer Res. 2009;15(12):4104\u201313.","journal-title":"Clin Cancer Res"},{"issue":"32","key":"3299_CR91","doi-asserted-by":"publisher","first-page":"51284","DOI":"10.18632\/oncotarget.9992","volume":"7","author":"X Wan","year":"2016","unstructured":"Wan X, Pu H, Huang W, Yang S, Zhang Y, Kong Z, et al. Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy. Oncotarget. 2016;7(32):51284\u2013300.","journal-title":"Oncotarget"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03299-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:02:20Z","timestamp":1742947340000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03299-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3299"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03299-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.16.603771","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical specimens were collected with informed consent from all subjects. The ethical approvals for these retrospective analyses were granted by the local Ethics Committees and Institutional Review Boards of the Faculty of Medicine, Technische Universit\u00e4t Dresden, Germany (BO-EK-470122024 and BO-EK-350082024) and the University of Manchester, Manchester Cancer Research Centre (#15\/NW\/0559).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In the past years, Dr. Mechthild Krause received funding for her research projects by IBA (2016), Merck KGaA (2014\u20132018 for preclinical study; 2018\u20132020 for clinical study), Medipan GmbH (2014\u20132018). In the past five years, Dr. Krause and Dr. Linge have been involved in a publicly funded (German Federal Ministry of Education and Research) project with the companies Medipan, Attomol GmbH, GA Generic Assays GmbH, Gesellschaft f\u00fcr medizinische und wissenschaftliche genetische Analysen, Lipotype GmbH and PolyAn GmbH (2019\u20132021). For the present manuscript, none of the above-mentioned funding sources were involved. All other authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}